Team:SCUT-China B/Overview
IGEM-China_B
Home
Project
Overview
Apoptosis Induction
Tumor specific promoter
Achievements
Results
Parts
Judging
Modeling
Apoptosis
CRISPRi/a
Notebook
Protocol
Safety
Human Practice
Overview
Project Design
Public Outreach
Hospice Care
Lab
Team
Collaborations
Attributions
Non-small cell lung cancer (NSCLC)
While Lung cancer is a common kind of cancer, non-small cell lung cancer belongs to lung cancer and takes the percentage of 80%-85% .Unlike most lung cancer , non-small cell cancer usually appears to occur in people who do not smoke.
According to the WHO Health statistics [1], the death rate of lung cancer is on the top among cancers. In particular, it is the leading cause of cancer death among males in both developed and undeveloped countries.
Figure 1. Death rate among cancers around the world, according to WHO Health statistics.
Therapy for NSCLC
Figure 2. According to Nccn clinical practice guidelines in oncology, non-small cell cancer. Current therapy for NSCLC[2], mainly consists of traditional therapy, small-molecule targeted drugs and cancer immunotherapy.
Overview
Apoptosis Induction
Tumor specific promoter
Non-small cell lung cancer (NSCLC)
Therapy for NSCLC
The whole pathway
